Rao Zhi-Li, Cao Hai-Juan, Shi Bo-Yu, Luo Jie, Liu Xiao-Bo, Zeng Nan
Pharmacy College of Chengdu University of Traditional Chinese Medicine Chengdu 611137,China.
Zhongguo Zhong Yao Za Zhi. 2019 Mar;44(5):1026-1033. doi: 10.19540/j.cnki.cjcmm.20181214.004.
The LPS-induced RAW264. 7 cells inflammation model was used as a carrier to investigate the in vitro anti-inflammation effects of Jingfang n-butanol extraction(JFNE) isolated fraction A and explore its preliminary anti-inflammation mechanism by observing the regulatory effect on PI3 K/AKT signaling pathway and NF-κB pathway. The RAW264. 7 cells inflammation model was established by stimulating with LPS for 12 h. After 3 h pre-treatment with fraction A,the contents of interleukin-6(IL-6),interleukin-1β(IL-1β) and tumor necrosis factor(TNF-α) in the supernatant of RAW264. 7 cells inflammation model were determined by ELISA and the contents of NO in supernatant were assayed by Griess. Reverse transcription-polymerase chain reaction(RT-PCR) method was used to determine the expression of IL-6,IL-1β,TNF-α,IFN-γ,i NOS,PI3 K,AKT,CHUK,NF-κB1 and Rela mRNA in RAW264. 7 inflammatory cells,and the expression levels of phosphorylated and total PI3 K/AKT protein,NF-κB p50,p65,p-p65,p105 protein in cells were determined via Western blot. In addition,LC-MS and database were used to identify the possible chemical constituents in fraction A. The results showed that fraction A could significantly reduce the release levels of NO,IL-6,IL-1β and TNF-α in the supernatant and the expression of IL-6,IL-1β,TNF-α,IFN-γ,i NOS,PI3 K,AKT,CHUK,NF-κB1 and Rela mRNA in RAW264. 7 inflammation model cells(P<0. 05 or P<0. 01) and significantly inhibit the phosphorylation expression levels of PI3 K and AKT protein and mRNA expressions(P<0. 05 or P<0. 01). Moreover,fraction A could significantly reduce the levels of NF-κB p50,p-p65 and i NOS protein,as well as NF-κB1,Rela mRNA expressions in RAW264. 7 cells,and increase the expression of CHUK gene.A total of 196 compounds were identified from fraction A in the composition analysis,and isoobtusilactone,5-O-methyl-vismitol,emebel(embelin) and prim-O-glucosylcimifugin showed high contents. The results all above showed that fraction A had a certain antiinflammatory effect in LPS-induced RAW264. 7 inflammation model cells,and its anti-inflammatory effects may be related to its regulatory effect on the activation of PI3 K/AKT signaling pathway and NF-kappa B signaling pathway. In addition,emblin may be its effective anti-inflammation chemical composition.
以脂多糖(LPS)诱导的RAW264.7细胞炎症模型为载体,研究荆防正丁醇提取物(JFNE)分离部位A的体外抗炎作用,并通过观察其对PI3K/AKT信号通路和NF-κB通路的调节作用,探讨其初步抗炎机制。用LPS刺激12小时建立RAW264.7细胞炎症模型。用部位A预处理3小时后,采用酶联免疫吸附测定法(ELISA)检测RAW264.7细胞炎症模型上清液中白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)和肿瘤坏死因子(TNF-α)的含量,采用格里斯试剂法检测上清液中一氧化氮(NO)的含量。采用逆转录-聚合酶链反应(RT-PCR)法检测RAW264.7炎症细胞中IL-6、IL-1β、TNF-α、干扰素-γ(IFN-γ)、诱导型一氧化氮合酶(iNOS)、PI3K、AKT、CHUK、NF-κB1和Rela mRNA的表达,并通过蛋白质免疫印迹法检测细胞中磷酸化和总PI3K/AKT蛋白、NF-κB p50、p65、磷酸化p65(p-p65)、p105蛋白的表达水平。此外,采用液相色谱-质谱联用(LC-MS)技术和数据库对部位A中可能的化学成分进行鉴定。结果表明,部位A能显著降低RAW264.7炎症模型细胞上清液中NO、IL-6、IL-1β和TNF-α的释放水平以及IL-6、IL-1β、TNF-α、IFN-γ、iNOS、PI3K、AKT、CHUK、NF-κB1和Rela mRNA的表达(P<0.05或P<0.01),并显著抑制PI3K和AKT蛋白的磷酸化表达水平及mRNA表达(P<0.05或P<0.01)。此外,部位A能显著降低RAW264.7细胞中NF-κB p50、p-p65和iNOS蛋白水平以及NF-κB1、Rela mRNA的表达,并增加CHUK基因的表达。在成分分析中,从部位A中共鉴定出196种化合物,其中异欧前胡内酯、5-O-甲基维斯阿米醇、恩贝林(embelin)和升麻素苷含量较高。上述结果表明,部位A在LPS诱导的RAW264.7炎症模型细胞中具有一定的抗炎作用,其抗炎作用可能与其对PI3K/AKT信号通路和NF-κB信号通路激活的调节作用有关。此外,恩贝林可能是其有效的抗炎化学成分。